4.7 Article

Enoxaparin and Pentosan Polysulfate Bind to the SARS-CoV-2 Spike Protein and Human ACE2 Receptor, Inhibiting Vero Cell Infection

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms

Giulia Paiardi et al.

Summary: Heparin has been found to have antiviral activity against SARS-CoV-2 by inhibiting viral binding to host cells, competing with binding to host heparan sulfate proteoglycan coreceptors, and preventing spike cleavage. These findings provide insights into potential strategies for SARS-CoV-2 antiviral therapy.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Spectroscopy

Heparin interacts with the main protease of SARS-CoV-2 and inhibits its activity

Jinwen Li et al.

Summary: Heparin interacts with SARS-CoV-2's M-pro and inhibits its activity, potentially playing a role in inhibiting the viral infection.

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2022)

Article Pharmacology & Pharmacy

Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations

Julia A. Tree et al.

Summary: A comparison of clinically relevant heparins showed that unfractionated heparin (UFH) has significantly stronger antiviral activity against SARS-CoV-2 compared to low molecular weight heparins (LMWHs), directly inhibiting the binding of spike protein to the human ACE2 receptor. These findings support further clinical investigation of UFH as a potential treatment for COVID-19 patients.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study

David Pereyra et al.

Summary: The study found that the use of low molecular weight heparin (LMWH) was associated with improved survival in COVID-19 patients, but did not reduce the increase in thromboinflammation. Instead, it reduced cell death and viral persistence, suggesting potential beneficial effects of LMWH beyond hemostasis in COVID-19 patients without contraindications.

CARDIOVASCULAR RESEARCH (2021)

Review Medicine, General & Internal

Clinical manifestations of COVID-19 in the general population: systematic review

Rodrigo da Rosa Mesquita et al.

Summary: This study systematically reviewed literature on the clinical manifestations of COVID-19 patients, identifying fever, cough, and dyspnea as the main symptoms. Other common symptoms included neurological symptoms, dermatological manifestations, and anorexia. Identifying all clinical manifestations is crucial for early diagnosis and prevention.

WIENER KLINISCHE WOCHENSCHRIFT (2021)

Article Multidisciplinary Sciences

Binding of the SARS-CoV-2 spike protein to glycans

Wei Hao et al.

Summary: The study found that the spike proteins and subunits of SARS-CoV-2, SARS-CoV, and MERS-CoV can bind to heparan sulfate (HS) in a sulfation-dependent manner, with no binding to sialic acid residues detected. This suggests that HS binding may be a general mechanism for these coronaviruses to attach to host cells.

SCIENCE BULLETIN (2021)

Review Biochemistry & Molecular Biology

Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm

Alexandra Pum et al.

Summary: The presence and involvement of specific chemokines are crucial for the development and progression of COVID-19, leading to severe respiratory distress syndrome and pneumonia with fatal consequences. Cytokine storm and the resulting cytokine release syndrome are pathophysiological hallmarks in severe cases of COVID-19 infections, where chemokines and other cytokines are highly upregulated and cause harmful effects. There are therapeutics in clinical development targeting these factors to potentially treat COVID-19 infections.

BIOMOLECULES (2021)

Article Chemistry, Multidisciplinary

Heparan Sulfate Proteoglycans as Attachment Factor for SARSCoV-2

Lin Liu et al.

Summary: The study revealed the binding capability of SARS-CoV-2 spike protein with heparan sulfate (HS) and highlighted the potential therapeutic use of HS oligosaccharides. Heparin showed a higher affinity for SARS-CoV-2 spike protein compared to the receptor binding domain (RBD) alone, inhibiting RBD binding to cells. The findings support a model where HS acts as the initial attachment point for the virus to travel through the glycocalyx and engage with ACE2 for cell entry.

ACS CENTRAL SCIENCE (2021)

Article Public, Environmental & Occupational Health

Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19

Wei-Xi Shen et al.

Summary: A practical model has been developed to identify the features of cytokine storm in COVID-19, revealing the pathogenesis of the disease and providing new insights for precision treatment.

FRONTIERS IN PUBLIC HEALTH (2021)

Article Biochemistry & Molecular Biology

Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain

Zachariah P. Schuurs et al.

Summary: A new GAG binding site was identified in the spike protein, which may be crucial for understanding recent UK and South African strains. These findings could also aid in future targeted therapy programs.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Article Virology

Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives

Ritesh Tandon et al.

Summary: SARS-CoV-2 virus relies on spike glycoprotein for cell entry, and several sulfated polysaccharides have shown potent neutralizing effects against the virus, demonstrating potential prophylactic and therapeutic applications.

JOURNAL OF VIROLOGY (2021)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Renhong Yan et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Cell entry mechanisms of SARS-CoV-2

Jian Shang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

Thomas Mandel Clausen et al.

Review Pharmacology & Pharmacy

The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review

Lucia Gozzo et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Chemistry, Medicinal

Inhibition of SARS-CoV-2 Entry into Host Cells Using Small Molecules

Kenana Al Adem et al.

PHARMACEUTICALS (2020)

Review Hematology

Using heparin molecules to manage COVID-2019

Jian Liu et al.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)

Article Biochemistry & Molecular Biology

Structural basis for human coronavirus attachment to sialic acid receptors

M. Alejandra Tortorici et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)

Review Pharmacology & Pharmacy

Pharmacology of Heparin and Related Drugs

Barbara Mulloy et al.

PHARMACOLOGICAL REVIEWS (2016)

Article Cell Biology

Heparan Sulfate Proteoglycans

Stephane Sarrazin et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)

Article Pharmacology & Pharmacy

Pharmacokinefics and pharmalcodynamics of oral heparin solid dosage form in healthy human subjects

Shaker A. Mousa et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2007)

Article Respiratory System

Matrix proteoglycans as effector molecules for epithelial cell function

C. W. Frevert et al.

EUROPEAN RESPIRATORY REVIEW (2005)

Review Biochemistry & Molecular Biology

Heparin and heparan sulfate: structure and function

DL Rabenstein

NATURAL PRODUCT REPORTS (2002)